Clinicaltrials.gov was looked for registered review protocols. The keywords “palmitoylethanolamide” and “agony” resulted in 13 entries, of which three have been concluded. None of these fulfilled our eligibility conditions. One motive for that substantial prevalence amount of Persistent ache, and specially neuropathic discomfort, is The shortage of effective solutions. https://troyyulbr.mdkblog.com/36158471/palmitoylethanolamide-options